Endothelial APLNR regulates tissue fatty acid uptake and is essential for apelin's glucose-lowering effects
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Hwangbo, Cheol | - |
dc.contributor.author | Wu, Jingxia | - |
dc.contributor.author | Papangeli, Irinna | - |
dc.contributor.author | Adachi, Takaomi | - |
dc.contributor.author | Sharma, Bikram | - |
dc.contributor.author | Park, Saejeong | - |
dc.contributor.author | Zhao, Lina | - |
dc.contributor.author | Ju, Hyekyung | - |
dc.contributor.author | Go, Gwang-woong | - |
dc.contributor.author | Cui, Guoliang | - |
dc.contributor.author | Inayathullah, Mohammed | - |
dc.contributor.author | Job, Judith K. | - |
dc.contributor.author | Rajadas, Jayakumar | - |
dc.contributor.author | Kwei, Stephanie L. | - |
dc.contributor.author | Li, Ming O. | - |
dc.contributor.author | Morrison, Alan R. | - |
dc.contributor.author | Quertermous, Thomas | - |
dc.contributor.author | Mani, Arya | - |
dc.contributor.author | Red-Horse, Kristy | - |
dc.contributor.author | Chun, Hyung J. | - |
dc.date.accessioned | 2022-07-13T11:29:21Z | - |
dc.date.available | 2022-07-13T11:29:21Z | - |
dc.date.created | 2021-05-14 | - |
dc.date.issued | 2017-09 | - |
dc.identifier.issn | 1946-6234 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/hanyang/handle/2021.sw.hanyang/151593 | - |
dc.description.abstract | Treatment of type 2 diabetes mellitus continues to pose an important clinical challenge, with most existing therapies lacking demonstrable ability to improve cardiovascular outcomes. The atheroprotective peptide apelin (APLN) enhances glucose utilization and improves insulin sensitivity. However, the mechanism of these effects remains poorly defined. We demonstrate that the expression of APLNR (APJ/AGTRL1), the only known receptor for apelin, is predominantly restricted to the endothelial cells (ECs) of multiple adult metabolic organs, including skeletal muscle and adipose tissue. Conditional endothelial-specific deletion of Aplnr (Aplnr(ECKO)) resulted in markedly impaired glucose utilization and abrogation of apelin-induced glucose lowering. Furthermore, we identified inactivation of Forkhead box protein O1 (FOXO1) and inhibition of endothelial expression of fatty acid (FA) binding protein 4 (FABP4) as key downstream signaling targets of apelin/APLNR signaling. Both the Apln(-/-) and AplnrECKO mice demonstrated increased endothelial FABP4 expression and excess tissue FA accumulation, whereas concurrent endothelial Foxo1 deletion or pharmacologic FABP4 inhibition rescued the excess FA accumulation phenotype of the Apln(-/-) mice. The impaired glucose utilization in the Aplnr(ECKO) mice was associated with excess FA accumulation in the skeletal muscle. Treatment of these mice with an FABP4 inhibitor abrogated these metabolic phenotypes. These findings provide mechanistic insights that could greatly expand the therapeutic repertoire for type 2 diabetes and related metabolic disorders. | - |
dc.language | 영어 | - |
dc.language.iso | en | - |
dc.publisher | AMER ASSOC ADVANCEMENT SCIENCE | - |
dc.title | Endothelial APLNR regulates tissue fatty acid uptake and is essential for apelin's glucose-lowering effects | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Go, Gwang-woong | - |
dc.identifier.doi | 10.1126/scitranslmed.aad4000 | - |
dc.identifier.scopusid | 2-s2.0-85029414682 | - |
dc.identifier.wosid | 000410560500001 | - |
dc.identifier.bibliographicCitation | SCIENCE TRANSLATIONAL MEDICINE, v.9, no.407, pp.1 - 14 | - |
dc.relation.isPartOf | SCIENCE TRANSLATIONAL MEDICINE | - |
dc.citation.title | SCIENCE TRANSLATIONAL MEDICINE | - |
dc.citation.volume | 9 | - |
dc.citation.number | 407 | - |
dc.citation.startPage | 1 | - |
dc.citation.endPage | 14 | - |
dc.type.rims | ART | - |
dc.type.docType | 정기학술지(Article(Perspective Article포함)) | - |
dc.description.journalClass | 1 | - |
dc.description.isOpenAccess | Y | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Cell Biology | - |
dc.relation.journalResearchArea | Research & Experimental Medicine | - |
dc.relation.journalWebOfScienceCategory | Cell Biology | - |
dc.relation.journalWebOfScienceCategory | Medicine, Research & Experimental | - |
dc.subject.keywordPlus | INDUCED INSULIN-RESISTANCE | - |
dc.subject.keywordPlus | IN-VIVO | - |
dc.subject.keywordPlus | PHENOTYPIC HETEROGENEITY | - |
dc.subject.keywordPlus | TRANSCRIPTION FACTORS | - |
dc.subject.keywordPlus | MOUSE | - |
dc.subject.keywordPlus | ANGIOGENESIS | - |
dc.subject.keywordPlus | TRANSPORT | - |
dc.subject.keywordPlus | REVEALS | - |
dc.subject.keywordPlus | OBESITY | - |
dc.subject.keywordPlus | HUMANS | - |
dc.identifier.url | https://www.science.org/doi/10.1126/scitranslmed.aad4000 | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
222, Wangsimni-ro, Seongdong-gu, Seoul, 04763, Korea+82-2-2220-1365
COPYRIGHT © 2021 HANYANG UNIVERSITY.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.